• Skip to main content
  • Skip to primary sidebar
virology blog

virology blog

About viruses and viral disease

kawaoka

Avian influenza virus transmission experiments proceed, as they should

4 April 2019 by Vincent Racaniello

ferretThe decision by the US government to allow the resumption of experiments on aerosol transmission of avian influenza viruses has once again raised the hackles of some individuals who feel that the work is too risky. I disagree with their view on this work.

Science reports that ‘Controversial lab studies that modify bird flu viruses in ways that could make them more risky to humans will soon resume after being on hold for more than 4 years’. Denise Grady of the New York Times wrote that “Research that could make flu viruses more dangerous” are set to resume. Note that the experiments done in the Kawaoka and Fouchier laboratories that allow aersol transmission of avian H5N1 viruses among ferrets discussed here previously actually made the viruses much less pathogenic. This fact is ignored in all the discourse about the work. [Read more…] about Avian influenza virus transmission experiments proceed, as they should

Filed Under: Basic virology, Commentary Tagged With: aerosol transmission, avian influenza, ferret, fouchier, gain of function, H5N1, influenza, kawaoka, viral, virology, virus, viruses

TWiV 354: The cat in the HAART

13 September 2015 by Vincent Racaniello

On episode #354 of the science show This Week in Virology, the esteemed doctors of TWiV review a new giant virus recovered from the Siberian permafrost, why influenza virus gain of function experiments are valuable, and feline immunodeficiency virus.

You can find TWiV #354 at www.microbe.tv/twiv.

Filed Under: This Week in Virology Tagged With: cat, feline immunodeficiency virus, FIV, gain of function, giant virus, influenza, kawaoka, Mollivirus, permafrost, Siberia, vaccine, viral, virology, virus

TWiV 321: aTRIP and a pause

25 January 2015 by Vincent Racaniello

On episode #321 of the science show This Week in Virology, Paul Duprex joins the TWiV team to discuss the current moratorium on viral research to alter transmission, range and resistance, infectivity and immunity, and pathogenesis.

You can find TWiV #321 at www.microbe.tv/twiv.

Filed Under: This Week in Virology Tagged With: aerosol transmission, apocalypse, aTRIP, ferret, fouchier, gain of function, H5N1, influenza virus, kawaoka, moratorium, National Academy of Sciences, nsabb, pause, rhetoric, viral, virology, virus

The value of influenza aerosol transmission experiments

4 July 2014 by Vincent Racaniello

ferretA Harvard epidemiologist has been on a crusade to curtail aerosol transmission experiments on avian influenza H5N1 virus because he believes that they are too dangerous and of little value. Recently he has taken his arguments to the Op-Ed pages of the New York Times. While Dr. Lipsitch is certainly entitled to his opinion, his arguments do not support his conclusions.

In early 2013 Lipsitch was the subject of a piece in Harvard Magazine about avian influenza H5N1 virus entitled The Deadliest Virus.  I have previously criticized this article  in which Lipsitch calls for more stringent H5N1 policies. More recently Lipsitch published an opinion in PLoS Medicine in which he called for alternatives to experiments with potential pandemic pathogens. We discussed this piece thoroughly on This Week in Virology #287.  The arguments he uses in both cases are similar to those in the OpEd.

The Times OpEd is entitled Anthrax? That’s not the real worry. The title is a reference to the possible exposure to anthrax bacteria of workers at the Centers for Disease Control. Even worse than anthrax, argues Lipsitch, would be accidental exposure to a pathogen that could transmit readily among humans. He then argues that such a pathogen is being created in laboratories that study avian influenza H5N1 transmission.

Lipsitch tells us ‘These experiments use flu strains like H5N1, which kills up to 60 percent of humans who catch it from birds.’ As an epidemiologist Lipsitch knows that this statement is wrong. The case fatality ratio for avian H5N1 influenza virus in humans is 60% – the number of deaths divided by the cases of human infections that are diagnosed according to WHO criteria. The mortality rate is quite different: it is the number of fatalities divided by the total number of H5N1 infections of humans. For a number of reasons the H5N1 mortality ratio in humans has been a difficult number to determine.

Next Lipsitch incorrectly states that the goal of experiments in which avian influenza H5N1 viruses are given the ability to transmit by aerosol among ferrets is ‘to see what gives a flu virus the potential to create a pandemic.’ The goal of these experiments is to identify mechanistically what is needed to make an avian influenza virus transmit among mammals. Transmission of a virus is required for a pandemic, but by no means does it assure one. I do hope that Lipsitch knows better, and is simply trying to scare the readers.

He then turns to the experiments of Kawaoka and colleagues who recently reconstructed a 1918-like avian influenza virus and provided it with the ability to transmit by aerosol among ferrets. These experiments are inaccurately described. Lipsitch writes that the reconstructed virus was ‘both contagious and comparably deadly to the 1918 flu that killed tens of millions of people worldwide’. In fact the reconstructed virus is less virulent in ferrets than the 1918 H1N1 virus that infected humans. In the same sentence Lipsitch mixes virulence in ferrets with virulence in humans – something even my virology students know is wrong. Then he writes that ‘Unlike experiments with anthrax, creating such flu strains in the lab presents a danger that affects us all, because once it is out, such a strain would be extremely hard to control.’ This is not true for the 1918-like avian influenza virus assembled by the Kawaoka lab: it was shown that antibodies to the 2009 pandemic H1N1 influenza virus can block its replication. The current influenza virus vaccine contains a 2009 H1N1 component that would protect against the 1918-like avian influenza virus.

The crux of the problem seems to be that Lipsitch does not understand the purpose of influenza virus transmission experiments. He writes that ‘The virologists conducting these experiments say that by learning about how flu transmits in ferrets, we will be able to develop better vaccines and spot dangerous strains in birds before they become pandemic threats.’ This justification for the work is wrong.

Both Kawaoka and Fouchier have suggested that identifying mutations that improve aerosol transmission of avian influenza viruses in ferrets might help to detect strains with transmission potential, and help vaccine manufacture. I think it was an error to focus on these potential benefits because it detracted from the real value of the work, to provide mechanistic information on what allows aerosol transmission of influenza viruses among mammals.

In the Kawaoka and Fouchier studies, it was found that adaptation of H5N1 influenza virus from avian to mammalian receptors lead to a decrease in the stability of the viral HA glycoprotein. This property had to be reversed in order for these viruses to transmit by aerosol among ferrets. Similar stabilization of the HA protein was observed when the reconstructed 1918-like avian influenza virus was adapted to aerosol transmission among ferrets. It is not simply coincidence when three independent studies come up with the same outcome: clearly HA stability is important for aerosol transmission among mammals. This is one property to look for in circulating H5N1 strains, not simply amino acid changes.

Lipsitch mentions nothing about the mechanism of transmission; he focuses on identifying mutations for surveillance and vaccine development. He ignores the fundamental importance of this work. In this context, the work has tremendous value.

The remainder of the Times OpEd reminds us how often accidents occur in high security biological labortories. There are problems with these arguments. Lipsitch cites the emergence of an H1N1 influenza virus in 1977 as ‘escaped from a lab in China or the Soviet Union’. While is seems clear that the 1977 H1N1 virus probably came from a laboratory, there is zero evidence that it was a laboratory accident. It is equally likely that the virus was part of a clinical trial in which it was deliberately administered to humans.

Lipsitch also cites the numerous incidents that occur in American laboratories involving select agents. I suggest the reader listen to Ron Fouchier explain on TWiV #291 how a computer crash must be recorded as an incident in high biosecurity laboratories, but does not lead to the release of infectious agents.

Lipsitch clearly feels that the benefits of aerosol transmission research do not justify the risks involved. I agree that the experiments do have some risk, but it is not as clear cut as Lipsitch would suggest. Although ferrets are a good model for influenza virus pathogenesis, like any animal model, they are not predictive of what occurs in humans. An influenza virus that transmits by aerosol among ferrets cannot be assumed to transmit in the same way among humans. This is the assumption made by Lipsitch, and it is wrong.

I agree that transmission work on avian H5N1 influenza virus must be done under the proper containment. Before these experiments can be done they are subject to extensive review of the proposed containment and mitigation procedures. There is no justification for the additional regulation proposed by Lipsitch.

In my opinion aerosol transmission experiments on avian influenza viruses are well worth the risk. We know nothing about what controls aerosol transmission of viruses. The way to obtain this information is to take a virus that does not transmit by aerosol, derive a transmissible version, and determine why the virus has this new property. To conclude that such experiments are not worth the risk not only ignores the importance of understanding transmission, but also fails to acknowledge the unpredictable nature of science. Often the best experimental results are those which were never anticipated.

Lipsitch ends by saying that ‘There are dozens of safe research strategies to understand, prevent and treat pandemic flu. Only one strategy — creating virulent, contagious strains — risks inciting such a pandemic.’ Creating a virulent strain is not part of the strategy. Lipsitch conveniently ignores the fact that Fouchier’s H5N1 strain that transmits by aerosol among ferrets is not virulent when transmitted by that route. And of course we do not know if these strains would be transmissible in humans.

I am very disappointed that the Times chose to publish this OpEd without checking Lipsitch’s statements. He is certainly entitled to his own opinion, but he is not entitled to his own facts.

Filed Under: Basic virology, Commentary, Information Tagged With: aerosol, avian H5N1, ferret, fouchier, gain of function, influenza, kawaoka, transmission, viral, virology, virus

TWiV 287: A potentially pandemic podcast

1 June 2014 by Vincent Racaniello

On episode #287 of the science show This Week in Virology, Matt Frieman updates the TWiV team on MERS-coronavirus, and joins in a discussion of whether we should further regulate research on potentially pandemic pathogens.

You can find TWiV #287 at www.microbe.tv/twiv.

Filed Under: This Week in Virology Tagged With: aerosol transmission, avian influenza H5N1, coronavirus, ferret, fouchier, gain of function, kawaoka, laboratory accident, MERS-CoV, Middle East respiratory syndrome, Nuremberg, pandemic, SARS, viral, virology, virus

Incidence of asymptomatic human influenza A(H5N1) virus infection

1 October 2013 by Vincent Racaniello

BangladeshWhen virologists Fouchier and Kawaoka were isolating avian influenza H5N1 viruses that could transmit among ferrets by aerosol, there was consternation from some quarters that such viruses might escape from the laboratory and cause a pandemic in humans. Part of the fear came from the fact that the case fatality ratio for human infections with the H5N1 virus exceeds 50%. This number could be substantially higher than the lethality ratio, which is the number of symptomatic cases divided by the total number of infections. Divining the latter number has been difficult. Results of a meta-analysis published in 2012 suggest that H5N1 seropositivity approaches 1-2% in certain populations. Others have concluded that these studies are flawed, clouded by false positives and cross-reacting antigens. Recently two additional studies have been published that contribute to this discussion.

The first paper is a case report of subclinical avian influenza H5N1 virus infection in a Vietnamese household in which family members were involved in slaughtering, preparing, and consuming chickens, and birds were permitted to roam freely in the sleeping area. Four chickens from this household were found to be positive for H5N1 virus by polymerase chain reaction (PCR) of throat and cloacal swab specimens. The 40-year old father died after a severe four day respiratory illness requiring hospitalization; H5N1 viral RNA was detected by PCR of a throat swab on day 3 of illness. A throat swab from his daughter, taken 6 days after she had killed a chicken, was positive by PCR, and H5N1 virus was recovered by inoculation of cell cultures. Her hemagglutination-inhibition (HI) titer, a measure of anti-viral antibodies, increased from <20 to 160, but she showed no signs of illness, perhaps because she was treated with oseltamivir from day 5 of her father’s illness.

The authors note the difficulty in detecting subclinical H5N1 infections:

…it is unclear whether serologic testing reliably detects subclinical cases. According to the World Health Organization,MN (microneutralization) titers >80 are indicative of infection but must be confirmed by a second serologic test because of the possibility of cross-reactivity. The interpretation of results from a single serum sample is limited by the specificity or sensitivity of serologic tests, and viral shedding times may mean that infected cases may be missed.

The second study examined seroprevalence of anti-H5N1 virus antibodies in poultry workers in Bangladesh. Sera were collected in 2009 from poultry workers on farms (212 from 87 farms) and live bird markets (210 from 3 markets). Some of the farm workers (91%) reported handling sick animals during laboratory-confirmed H5N1 outbreaks. Sera were screened for antibodies to H5N1 virus by two methods: microneutralization and hemagglutination-inhibition. None of the individuals were seropositive for anti-H5N1 virus antibodies.

I have several reservations about this study. Although H5N1 virus was identified on the poultry farms whose workers were sampled, the sera were drawn from 22 to 543 days after the onset of poultry deaths. If any of the workers had been infected with H5N1 virus, anti-viral antibody titers might have already declined by this time. Although the sera were examined for anti-viral antibodies by two different tests, paired sera were not used, as recommended by the authors of the first paper discussed above.

Therefore the answer to the question ‘what is the fatality rate of influenza H5n1 virus infections in humans?’ still cannot be answered. As the authors of the first paper conclude:

Estimating the incidence of asymptomatic influenza A(H5N1) virus infection in humans exposed to sick poultry or human case-patients requires further careful study using early collection of swab samples and paired acute and convalescent serum samples.

Filed Under: Basic virology, Information Tagged With: asymptomatic, avian, Bangladesh, case fatality ratio, fouchier, influenza A(H5N1), kawaoka, mortality ratio, viral, virology, virus

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to Next Page »

Primary Sidebar

by Vincent Racaniello

Earth’s virology Professor
Questions? virology@virology.ws

With David Tuller and
Gertrud U. Rey

Follow

Facebook, Twitter, YouTube, Instagram
Get updates by RSS or Email

Contents

Table of Contents
ME/CFS
Inside a BSL-4
The Wall of Polio
Microbe Art
Interviews With Virologists

Earth’s Virology Course

Virology Live
Columbia U
Virologia en Español
Virology 101
Influenza 101

Podcasts

This Week in Virology
This Week in Microbiology
This Week in Parasitism
This Week in Evolution
Immune
This Week in Neuroscience
All at MicrobeTV

Useful Resources

Lecturio Online Courses
HealthMap
Polio eradication
Promed-Mail
Small Things Considered
ViralZone
Virus Particle Explorer
The Living River
Parasites Without Borders

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.